Boehringer Ingelheim Introduces LENZELTA: Vaccine Advancing Mastitis Prevention in Dairy Cows
April 14, 2026
April 14, 2026
INGELHEIM AM RHEIN, Germany, April 14 -- Boehringer Ingelheim, a pharmaceutical company, issued the following news release:
* * *
Boehringer Ingelheim introduces LENZELTA(R): A new vaccine advancing mastitis prevention in dairy cows
* LENZELTA(R) is a new vaccine significantly reducing the incidence and severity of clinical mastitis in vaccinated cows and heifers/1. Administration is simple with two doses during the dry-off period.
* Mastitis c . . .
* * *
Boehringer Ingelheim introduces LENZELTA(R): A new vaccine advancing mastitis prevention in dairy cows
* LENZELTA(R) is a new vaccine significantly reducing the incidence and severity of clinical mastitis in vaccinated cows and heifers/1. Administration is simple with two doses during the dry-off period.
* Mastitis c . . .